We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Altus Pharmaceuticals Reacquires ALTU-238 Global Development and Commercialization Rights

News   Dec 24, 2007

 
Altus Pharmaceuticals Reacquires ALTU-238 Global Development and Commercialization Rights
 
 
 

RELATED ARTICLES

Receptor Blueprint Helps Design Osteoporosis Drugs

News

Researchers at the University of Zurich have determined the three-dimensional structure of a receptor that controls the release of calcium from bones. The receptor is now one of the main candidates for developing new drugs to treat osteoporosis.

READ MORE


1 in 4 Statisticians Asked to Commit Scientific Fraud

News

A stunning report concludes that researchers often ask statisticians to make "inappropriate requests." Not accidental requests for incorrect statistical analyses; but unscrupulous data manipulation or even fraud.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE